Explore Our Network
Explore MTEC's network of innovators, investors, and research organizations—along with patents and funding opportunities—advancing medical technologies for military and civilian health.
Showing 1 Patents
Exposing lymphocytes to anthrax lethal toxin; contacting the lymphocytes with a test agent; detecting a mitogen-activated protein kinase kinase-dependent cytokine response; increased response or increase in lymphocyte proliferation indicates that the lymphocyte-associated activity is decreased
28-09-2010 • US-7803565-B1
FRUCHT, DAVID M. • FANG, HUI
US Department of Health and Human Services